of PATient Education Related to CV Risk factOrs in Type 2 Diabetes Mellitus(Patrol). (DART)

AstraZeneca

Status: Completed

Conditions: Low Density Lipoprotein Cholesterol Goal Achievement

Study type: Observational

Funder types: Industry

Identifiers

NCT00925717

NIS-CKR-DUM-2009/1

Details and patient eligibility

About

An observational, non-interventional, multi-centre study to provide further information on the utility of test for a predictive marker by investigating the current prevalence of high sensitivity CRP (hs-CRP) testing and characteristics of each CVD risk group.

Enrollment: 4,045 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subjects who was diagnosed as diabetes
• Subjects who was diagnosed as dyslipidaemia or takes lipid lowering medication
• Clinic visit in the past 6 months more than once

Exclusion criteria

• Subjects who are unwilling or unable to provide their examination and lab result of medical chart.

Trial design

4,045 participants in 1 patient group

2500 patients

Description:

Who have records of clinic visit with endocrine internal medicines of nationwide secondary/tertiary hospitals within the last six months.